060IC - Managing Toxicities of Checkpoint Inhibitors: A Urologist's Guide

Sunday, April 30, 2023

1:30 PM – 3:30 PM CST

Location: S102B

Instructional Course Director(s)

Gautam Jayram, MD

Advanced Therapeutics Center, Urology Associates, PC

Instructional Course Faculty(s)

MJ

Michael Johnson, MD,FACS
Brian Rini, MD

Vanderbilt

Course Description: Checkpoint inhibitors (CPIs) are increasingly being utilized in the treatment of urinary tract cancers, with several approvals in metastatic and now nonmetastatic spaces in bladder, kidney and prostate cancer. Urologists are encountering many patients on these therapies and have even started their own infusion programs with immuno -oncology drugs. This course will discuss and provide a structured, case-based approach to managing toxicities from CPIs within a busy urological practice. The course is structured around six to eight real-world cases which cover the spectrum from “typical” to “atypical” adverse events. The course will focus on prevention, routine treatment and complex multidisciplinary treatment of immune-mediated adverse events.

Learning Objectives:

Identify common and uncommon clinical presentations of immune-mediated adverse events.
Successfully manage adverse events from CPIs.
Develop clinical infrastructure to prevent and prepare patients and providers for immune-mediated adverse events.